TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.

J Randolph Hecht et al.PubMed ↗Publisher ↗

No numbers read from the abstract.